<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02453841</url>
  </required_header>
  <id_info>
    <org_study_id>IRB14-00723</org_study_id>
    <nct_id>NCT02453841</nct_id>
  </id_info>
  <brief_title>Prospective Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption</brief_title>
  <official_title>Prospective Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption During Functional Endoscopic or Turbinate Reduction Surgery or Adenoidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Richard Cartabuke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This proposed study will assess the hemodynamic effects and measure the systemic absorption
      of topically applied oxymetazoline in patients undergoing functional endoscopic sinus
      surgery, turbinate surgery, or adenoidectomy. These patients will be receiving oxymetazoline
      as standard of care during the surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">April 20, 2017</completion_date>
  <primary_completion_date type="Actual">April 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in plasma levels of oxymetazoline</measure>
    <time_frame>5, 10, 20, 45, 90, &amp; 150 mins. after administration</time_frame>
    <description>Change in amount of oxymetazoline in the plasma over time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ease of hemostasis</measure>
    <time_frame>intraoperative</time_frame>
    <description>A six point scale completed by the surgeon at the end of surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of bleeding</measure>
    <time_frame>intraoperative</time_frame>
    <description>A four point scale completed by the surgeon after removal of the oxymetazoline soaked pledgets.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Adenoidectomy</condition>
  <condition>Functional Endoscopic Sinus Surgery (FESS)</condition>
  <condition>Turbinate Surgery</condition>
  <arm_group>
    <arm_group_label>FESS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing functional endoscopic sinus surgery and receiving oxymetazoline as part of their surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Turbinates</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing turbinate reduction surgery and receiving oxymetazoline as part of their surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adenoidectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing an adenoidectomy and receiving oxymetazoline as part of their surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxymetazoline</intervention_name>
    <arm_group_label>FESS</arm_group_label>
    <arm_group_label>Turbinates</arm_group_label>
    <arm_group_label>Adenoidectomy</arm_group_label>
    <other_name>Afrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients that are scheduled for:

               1. Functional endoscopic sinus surgery

               2. Turbinate reduction (with or without tonsillectomy and/or adenoidectomy)

               3. Adenoidectomy

        Exclusion Criteria:

          -  Been treated with oral decongestants or antihistamines within 24 hours of surgery

          -  Are taking anticoagulants

          -  Have a history of nasal trauma

          -  Have a history of epistaxis

          -  Have a history of hypertension or cardiac disease

          -  Allergy to oxymetazoline
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Cartabuke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nationwide Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2015</study_first_submitted>
  <study_first_submitted_qc>May 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2015</study_first_posted>
  <last_update_submitted>January 3, 2018</last_update_submitted>
  <last_update_submitted_qc>January 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Richard Cartabuke</investigator_full_name>
    <investigator_title>Co-Director of Outpatient Anesthesia Services</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxymetazoline</mesh_term>
    <mesh_term>Phenylephrine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

